Int J Thyroidol.  2020 Nov;13(2):65-71. 10.11106/ijt.2020.13.2.65.

The Management of Thyroid Disease in COVID-19 Pandemic

Affiliations
  • 1Division of Endocrinology, Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea

Abstract

The novel viral disease COVID-19 is spreading globally, causing countless infected individuals and deaths. There are active discussions and debates on how to manage patients with chronic illnesses in the COVID-19 pandemic era. Since thyroid diseases are chronic and associated with autoimmune diseases as well as high tumors, there is a need to assess the association between thyroid diseases and COVID-19. Recently, the American Thyroid Association and European Thyroid Association published a statement on thyroid disease management during the COVID-19 pandemic. Further, clinical data from COVID-19 patients also indicate that COVID-19 may affect thyroid functions. Therefore, we reviewed published literature on COVID-19 and thyroid diseases and discussed approaches to proper management of thyroid diseases during the COVID-19 pandemic.

Keyword

COVID-19; Thyroid disease
Full Text Links
  • IJT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
    DB Error: unknown error